Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study.
Prisco MG, Zannoni GF, De Stefano I, Vellone VG, Tortorella L, Fagotti A, Mereu L, Scambia G, Gallo D.
Hum Pathol. 2012 Feb;43(2):282-8. Epub 2011 Aug 10.
Related citations
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.
Kurman RJ, Shih IeM.
Hum Pathol. 2011 Jul;42(7):918-31. Review.
Thyroid transcription factor-1 expression in endometrioid tumors: a note of caution.
Cameselle-Teijeiro J, Abdulkader I, Piso-Neira M, Reyes-Santías R, Alfonsin-Barreiro N.
Hum Pathol. 2011 Jul;42(7):1053-5; author reply 1055-6. No abstract available.
PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
Konopka B, Janiec-Jankowska A, Kwiatkowska E, Najmoła U, Bidziński M, Olszewski W, Goluda C.
Hum Pathol. 2011 Nov;42(11):1710-9. Epub 2011 Apr 29.
JAZF1 and JJAZ1 gene fusion in primary extrauterine endometrial stromal sarcoma.
Amador-Ortiz C, Roma AA, Huettner PC, Becker N, Pfeifer JD.
Hum Pathol. 2011 Jul;42(7):939-46. Epub 2011 Feb 11.
Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome.
Davidson B, Holth A, Moripen L, Trope' CG, Shih IeM.
Hum Pathol. 2011 Jul;42(7):991-7. Epub 2011 Feb 11.
Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.
Hetland TE, Hellesylt E, Flørenes VA, Tropé C, Davidson B, Kærn J.
Hum Pathol. 2011 Jul;42(7):1019-26. Epub 2011 Feb 11.
Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia.
Wang HY, Huang LJ, Liu Z, Garcia R, Li S, Galliani CA.
Hum Pathol. 2011 May;42(5):749-58. Epub 2011 Jan 15.
Overexpression of cofilin 1 can predict progression-free survival in patients with epithelial ovarian cancer receiving standard therapy.
Nishimura S, Tsuda H, Kataoka F, Arao T, Nomura H, Chiyoda T, Susumu N, Nishio K, Aoki D.
Hum Pathol. 2011 Apr;42(4):516-21. Epub 2011 Jan 14.
Ovarian clear cell carcinomas: RHO GTPases may contribute to explain their singular biologic behavior.
Canet B, Pons C, Espinosa I, Prat J.
Hum Pathol. 2011 Jun;42(6):833-9. Epub 2011 Jan 3.
Ovarian ependymomas of extra-axial type or central immunophenotypes.
Stolnicu S, Furtado A, Sanches A, Nicolae A, Preda O, Hincu M, Nogales FF.
Hum Pathol. 2011 Mar;42(3):403-8. Epub 2010 Dec 30.
Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors.
Artero-Castro A, Castellvi J, García A, Hernández J, Ramón y Cajal S, Lleonart ME.
Hum Pathol. 2011 Feb;42(2):194-203. Epub 2010 Oct 30.
Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma.
Planagumà J, Liljeström M, Alameda F, Bützow R, Virtanen I, Reventós J, Hukkanen M.
Hum Pathol. 2011 Jan;42(1):57-67. Epub 2010 Oct 20.
Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer.
Nakamura M, Kyo S, Zhang B, Zhang X, Mizumoto Y, Takakura M, Maida Y, Mori N, Hashimoto M, Ohno S, Inoue M.
Hum Pathol. 2010 Nov;41(11):1516-29. Epub 2010 Aug 30.
The chromosome Y-linked testis-specific protein locus TSPY1 is characteristically present in gonadoblastoma.
Hertel JD, Huettner PC, Dehner LP, Pfeifer JD.
Hum Pathol. 2010 Nov;41(11):1544-9. Epub 2010 Jul 24.
Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L, Zhang S, Talerman A, Roth LM.
Hum Pathol. 2010 May;41(5):716-23. Epub 2010 Jan 21.
Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma.
Bunkholt Elstrand M, Dong HP, Ødegaard E, Holth A, Elloul S, Reich R, Tropé CG, Davidson B.
Hum Pathol. 2010 Jun;41(6):794-804. Epub 2010 Feb 12.
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Zhang C, Wang YE, Zhang P, Liu F, Sung CJ, Steinhoff MM, Quddus MR, Lawrence WD.
Hum Pathol. 2010 Feb;41(2):255-61. Epub 2009 Nov 6.
Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor.
Fujiwara S, Nawa A, Nakanishi T, Shimoyama Y, Kajiyama H, Shibata K, Ino K, Nakamura S, Kikkawa F, Yatabe Y.
Hum Pathol. 2010 Apr;41(4):560-5. Epub 2009 Dec 11.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on